Praxis Precisions Medicines Inc (PRAX) Event June 06, 2022, 11:45 UTC 21 1 comments (99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Announces Clinical Development Update Comment Full text
Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS) Event June 06, 2022, 11:38 UTC 22 1 comments (90% Positive) RADIUS HEALTH, INC. (RDUS) Files Form 8-K Comment Full text
Arbutus Biopharma Corporation (ABUS) Event June 06, 2022, 11:31 UTC 21 1 comments (85% Positive) Arbutus Biopharma Corporation (ABUS) Provides Update on patients for a Phase 2a clinical trial Comment Full text
AstraZeneca (AZN) Event June 06, 2022, 11:23 UTC 21 1 comments (10% Negative) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT) Event June 06, 2022, 10:30 UTC 22 1 comments (10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Announces Delay in trial Trials for liver fibrosis due to NASH Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
BioNTech SE (BNTX) Event June 06, 2022, 10:10 UTC 19 1 comments (10% Negative) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Comment Full text
Legend Biotech (LEGN) Event June 06, 2022, 10:00 UTC 18 1 comments (10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K) Comment Full text
Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) Event June 03, 2022, 21:15 UTC 19 1 comments (99% Neutral) Turning Point Therapeutics, Inc. (TPTX) Announces Business Combination Comment Full text
Aclaris Therapeutics Inc (ACRS) Event June 03, 2022, 21:15 UTC 19 1 comments (99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces Regulatory Update Comment Full text
Harpoon Therapeutics Inc (was acquisited by Merck (NYSE:MRK) on 11/03/2024) (HARP) Event June 03, 2022, 21:05 UTC 19 1 comments (70% Positive) Harpoon Therapeutics, Inc. (HARP) Announces Clinical Development Update Comment Full text